NOTCH1 and hematopoietic and lymphoid cell neoplasm: We found enrichment in NOTCH1 missense mutations in the PEST and the Lin-12/NOTCH repeat 3 (LNR3) domains relative to the expected numbers, which was consistent with reports that mutations in these regulatory regions lead to NOTCH1 activation in hematological cancers [48].